Ankylosis - 220 Studies Found
| Completed |
: An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 : Ankylosing Spondylitis : 2012-03-23 : Biological: Infliximab CT-P13 (5mg/kg) administered as a 2-hour IV infusion per dose |
| Completed |
: Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy : Ankylosing Spondylitis : 2012-01-15 : Drug: Total Glucosides Paeony Capsules Total Glucosides Paeony Capsules, oral, 0.3 gram per capsule, 3 c |
| Completed |
: Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. : Ankylosing Spondylitis : 2011-08-19 : Drug: Enbrel Enbrel |
| Completed |
: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) : Ankylosing Spondylitis : 2011-08-11 : Biological: Human umbilical cord-derived MSCs 1.0E+6 MSC/kg, IV drop and repeat repeated after three mon |
| Completed |
: Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population : Ankylosing Spondylitis : 2011-05-24 :
|
| Completed |
: 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis : Ankylosing Spondylitis : 2011-05-19 :
|
| Completed |
: Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis : Ankylosing Spondylitis : 2011-05-09 :
|
| Completed |
: Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis : Ankylosing Spondylitis : 2011-04-05 : Drug: Ustekinumab Ustekinumab 90 mg given subcutaneously at weeks 0, 4, and 16 |
| Active, not recruiting |
: Etanercept (Enbrel) in Ankylosing Spondylitis : Ankylosing Spondylitis : 2011-02-01 : Drug: Etanercept Etanercept 25 mg subcutaneously twice a week |
| Active, not recruiting |
: European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study : Ankylosing Spondylitis : 2011-01-27 |